0006-3931 : Zioptan .0045 mg/.3ml Ophthalmic Solution
NDC: | 0006-3931 |
Labeler: | Merck Sharp & Dohme Corp. |
Product Type: | Human Prescription Drug |
Drug Name: | Zioptan |
Dosage Form: | Ophthalmic Solution |
Application #: | NDA202514 |
Rev. Date: |
NDC Package Codes:
- 0006-3931-30: 3 POUCH IN 1 CARTON (0006‑3931‑30) > 10 AMPULE IN 1 POUCH (0006‑3931‑10) > .3 ML IN 1 AMPULE
- 0006-3931-36: 1 POUCH IN 1 CARTON (0006‑3931‑36) > 10 AMPULE IN 1 POUCH > .3 ML IN 1 AMPULE
- 0006-3931-54: 9 POUCH IN 1 CARTON (0006‑3931‑54) > 10 AMPULE IN 1 POUCH (0006‑3931‑10) > .3 ML IN 1 AMPULE
Active Ingredients:
- Tafluprost
Dosage Strength:
- .0045 mg/.3mL
Pharmaceutical Classes:
- Prostaglandin Analog [EPC]
- Prostaglandin Receptor Agonists [MoA]
- Increased Prostaglandin Activity [PE]
- Prostaglandins [Chemical/Ingredient]
Related Products:
Based on records with the same trade name.- 17478-609 Zioptan .0045 mg/.3ml Ophthalmic Solution/ Drops by Akorn, Inc.
- 82584-609 Zioptan .015 mg/ml Ophthalmic Solution/ Drops by Thea Pharma Inc.
NDC QR Code
Scan the QR code below to easily reference this data in the future:< Prev: 0006-3919Next: 0006-3941 >
Related Discussions:
tafluprost
pharmacokinetic and pharmacodynamic...
pharmacokinetic and pharmacodynamic...
Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.